Related Experiment Videos
CD69 is expressed on platelets and mediates platelet activation and aggregation
R Testi1, F Pulcinelli, L Frati
1Department of Experimental Medicine, University of L'Aquila, Italy.
The Journal of Experimental Medicine
|September 1, 1990
Summary
CD69, an early activation antigen, is constitutively expressed on human platelets. Its stimulation triggers platelet aggregation, degranulation, and arachidonic acid metabolism, suggesting a broader role in cell signaling.
Area of Science:
- Immunology
- Cell Biology
- Hematology
Background:
- CD69 is recognized as an early activation antigen primarily found on lymphocytes.
- Its expression and function on non-lymphoid cells, such as platelets, remain less understood.
Purpose of the Study:
- To investigate the presence and function of CD69 on human platelets.
- To elucidate the signaling pathways involved in CD69-mediated platelet activation.
Main Methods:
- Biochemical analysis (SDS-PAGE) to characterize platelet CD69.
- Monoclonal antibody stimulation to induce CD69 activation.
- Measurement of platelet aggregation, calcium influx, ATP release, and eicosanoid production.
Main Results:
- CD69 is constitutively expressed on human platelets, biochemically resembling lymphoid CD69.
- Stimulation of platelet CD69 induces dose-dependent aggregation, calcium influx, and degranulation.
- CD69 activation promotes thromboxane B2 and PGE2 production, indicating arachidonic acid metabolism activation.
Conclusions:
- Platelet CD69 functions as an activating molecule, similar to its role in lymphocytes.
- CD69 engagement on platelets initiates signaling cascades involving aggregation, degranulation, and eicosanoid synthesis.
- These findings suggest a more general role for CD69 in cellular signal transduction beyond lymphocytes.